Cập nhật về giang mai thần kinh

Lukehart SA, Hook EW III, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855–862. Wharton M, Chorba TL, Vogt RL, et al.: Case definitions for public health surveillance. MMWR Recomm Rep 1990, 39:1–43. Marra CM, Maxwell CL, Collier AC, et al.: Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007, 7:37. Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369–376. Ghanem KG, Moore RD, Rompalo AM, et al.: Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008, 22:1145–1151. Timmermans M, Carr J: Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 2004, 75:1727–1730. Hooshmand H, Escobar MR, Kopf SW: Neurosyphilis. A study of 241 patients. JAMA 1972, 219:726–729. Castro R, Prieto ES, da Luz Martins Pereira F: Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. J Clin Lab Anal 2008, 22:257–261. Larsen SA, Hambie EA, Wobig GH, Kennedy EJ: Cerebrospinal fluid serologic test for syphilis: treponemal and nontreponemal tests. In Advances in Sexually Transmitted Diseases. Edited by Morisset R, Kurstak E. Utrecht, The Netherlands: VNU Science Press; 1985:157–162. Davis LE, Schmitt JW: Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989, 25:50–55. Marra CM, Critchlow CW, Hook EW III, et al.: Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995, 52:68–72. Marra CM, Tantalo LC, Maxwell CL, et al.: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIVinfected individuals. Neurology 2004, 63:85–88. Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55:1–94. Symptomatic early neurosyphilis among HIV-positive men who have sex with men-four cities, United States, January 2002–June 2004. MMWR Morb Mortal Wkly Rep 2007, 56:625–628. Hughes GB, Rutherford I: Predictive value of serologic tests for syphilis in otology. Ann Otol Rhinol Laryngol 1986, 95:250–259. Becker GD: Late syphilitic hearing loss: a diagnostic and therapeutic dilemma. Laryngoscope 1979, 89:1273–1288. Yimtae K, Srirompotong S, Lertsukprasert K: Otosyphilis: a review of 85 cases. Otolaryngol Head Neck Surg 2007, 136:67–71. Jeans AR, Wilkins EG, Bonington A: Sensorineural hearing loss due to secondary syphilis. Int J STD AIDS 2008, 19:355–356. Klemm E, Wollina U: Otosyphilis: report on six cases. J Eur Acad Dermatol Venereol 2004, 18:429–434. Mishra S, Walmsley SL, Loutfy MR, et al.: Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada. AIDS Patient Care STDS 2008, 22:213–219. Song JJ, Lee HM, Chae SW, Hwang SJ: Bilateral otosyphilis in a patient with HIV infection. Eur Arch Otorhinolaryngol 2005, 262:972–974. Aldave AJ, King JA, Cunningham ET Jr: Ocular syphilis. Curr Opin Ophthalmol 2001, 12:433–441. Ormerod LD, Puklin JE, Sobel JD: Syphilitic posterior uveitis: correlative findings and significance. Clin Infect Dis 2001, 32:1661–1673. Zwink FB, Dunlop EM: Clinically silent anterior uveitis in secondary syphilis. Trans Ophthalmol Soc U K 1976, 96:148–150. Kitson MT, Yong MK, Hoy JF: Ocular syphilis: are we seeing all there is to see? Med J Aust 2008, 189:411. Joseph A, Rogers S, Browning A, et al.: Syphilitic acute posterior placoid chorioretinitis in nonimmuno-compromised patients. Eye 2007, 21:1114–1119. Chao JR, Khurana RN, Fawzi AA, et al.: Syphilis: reemergence of an old adversary. Ophthalmology 2006, 113:2074–2079. Doris JP, Saha K, Jones NP, Sukthankar A: Ocular syphilis: the new epidemic. Eye 2006, 20:703–705. Parc CE, Chahed S, Patel SV, Salmon-Ceron D: Manifestations and treatment of ocular syphilis during an epidemic in France. Sex Transm Dis 2007, 34:553–556. Balba GP, Kumar PN, James AN, et al.: Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med 2006, 119:448 e21–5. Kiss S, Damico FM, Young LH: Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20:161–167. Zamani M, Garfinkel RA: Corticosteroid-induced modulation of acute syphilitic posterior placoid chorioretinitis. Am J Ophthalmol 2003, 135:891–894. Erol N, Topbas S: Acute syphilitic posterior placoid chorioretinitis after an intravitreal triamcinolone acetonide injection. Acta Ophthalmol Scand 2006, 84:435. Song JH, Hong YT, Kwon OW: Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection. Graefes Arch Clin Exp Ophthalmol 2008, 246:1775–1778. Gordon SM, Eaton ME, George R, et al.: The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994, 331:1469–1473. Fathilah J, Choo MM: The Jarisch-Herxheimer reaction in ocular syphilis. Med J Malaysia 2003, 58:437–439. Gurses C, Bilgic B, Topcular B, et al.: Clinical and magnetic resonance imaging findings of HIV-negative patients with neurosyphilis. J Neurol 2007, 254:368–374. Noone ML, Sinha S, Taly AB, Chandrika S: Periodic lateralized epileptiform discharges in neurosyphilis. Epilepsia 2007, 48:390–393. Chang YP, Lin RT, Liu CK, et al.: Neurosyphilis presenting with status epilepticus. Neurologist 2006, 12:314–317. Bash S, Hathout GM, Cohen S: Mesiotemporal T2-weighted hyperintensity: neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol 2001, 22:314–316. Szilak I, Marty F, Helft J, Soeiro R: Neurosyphilis presenting as herpes simplex encephalitis. Clin Infect Dis 2001, 32:1108–1109. Marano E, Briganti F, Tortora F, et al.: Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 2004, 75:833. Lansberg MG, O’Brien MW, Norbash AM, et al.: MRI abnormalities associated with partial status epilepticus. Neurology 1999, 52:1021–1027. Hicdonmez T, Utku U, Turgut N, et al.: Reversible postictal MRI change mimicking structural lesion. Clin Neurol Neurosurg 2003, 105:288–290. Polnikorn N, Witoonpanich R, Vorachit M, et al.: Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. Br J Vener Dis 1980, 56:363–367. van der Valk PG, Kraai EJ, van Voorst Vader PC, et al.: Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis. Genitourin Med 1988, 64:223–225. Tramont EC: Persistence of Treponema pallidum following penicillin G therapy. Report of two cases. JAMA 1976, 236:2206–2207. Berry CD, Hooton TM, Collier AC, Lukehart SA: Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987, 316:1587–1589. Walter T, Lebouche B, Miailhes P, et al.: Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis 2006, 43:787–790. Richards BW, Hessburg TJ, Nussbaum JN: Recurrent syphilitic uveitis. N Engl J Med 1989, 320:62. Taylor MM, Aynalem G, Olea LM, et al.: A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001–2004. Sex Transm Dis 2008, 35:430–434. Poliseli R, Vidal JE, Penalva De Oliveira AC, Hernandez AV: Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis. Sex Transm Dis 2008, 35:425–429. Libois A, De Wit S, Poll B, et al.: HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007, 34:141–144. Zetola NM, Klausner JD: Syphilis and HIV infection: an update. Clin Infect Dis 2007, 44:1222–1228. Moore J: Studies in asymptomatic neurosyphilis II. The classification, treatment, and prognosis of early asymptomatic neurosyphilis. Bull Johns Hopkins Hosp 1922, 33:231–246. Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997, 337:307–314. Shann S, Wilson J: Treatment of neurosyphilis with ceftriaxone. Sex Transm Infect 2003, 79:415–416. Dowell ME, Ross PG, Musher DM, et al.: Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992, 93:481–488. Marra CM, Boutin P, McArthur JC, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virusinfected individuals. Clin Infect Dis 2000, 30:540–544. Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001–1006. Marra CM, Maxwell CL, Tantalo LC, et al.: Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008, 47:893–899.